Johns Hopkins University Hemophilia Treatment Center is a clinical research site located in Baltimore, Maryland, United States 21287.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Johns Hopkins University Hemophilia Treatment Center has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Hematologic Disorder, Bleeding Disorder, Connective Tissue Disorder.
Sponsors: American Thrombosis and Hemostasis Network.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Johns Hopkins University Hemophilia Treatment Center has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Johns Hopkins University Hemophilia Treatment Center has 1 clinical trials on record, with 1 currently active. Their work covers Hematologic Disorder, Bleeding Disorder, Connective Tissue Disorder.
Johns Hopkins University Hemophilia Treatment Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.